HKD 0.24
(9.26%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 215.59 Million HKD | 3.01% |
2022 | 209.3 Million HKD | 1.02% |
2021 | 207.18 Million HKD | -28.0% |
2020 | 287.76 Million HKD | 8.01% |
2019 | 266.41 Million HKD | 2.95% |
2018 | 258.78 Million HKD | 44.27% |
2017 | 179.36 Million HKD | 8.64% |
2016 | 165.09 Million HKD | -3.34% |
2015 | 170.8 Million HKD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 38.54 Million HKD | -73.56% |
2024 Q2 | 77.08 Million HKD | 100.0% |
2023 Q2 | 56.03 Million HKD | 307.09% |
2023 Q3 | 115.08 Million HKD | 105.37% |
2023 Q4 | 145.79 Million HKD | 26.68% |
2023 Q1 | 13.76 Million HKD | -55.4% |
2023 FY | 215.59 Million HKD | 3.01% |
2022 Q2 | 40.11 Million HKD | 58.61% |
2022 FY | 209.3 Million HKD | 1.02% |
2022 Q4 | 30.86 Million HKD | -72.7% |
2022 Q3 | 113.03 Million HKD | 181.8% |
2022 Q1 | 25.29 Million HKD | -29.43% |
2021 FY | 207.18 Million HKD | -28.0% |
2021 Q4 | 35.83 Million HKD | -66.21% |
2021 Q3 | 106.06 Million HKD | 227.87% |
2021 Q2 | 32.35 Million HKD | -1.74% |
2021 Q1 | 32.92 Million HKD | -56.09% |
2020 Q3 | 125.06 Million HKD | 100.3% |
2020 Q2 | 62.43 Million HKD | 146.86% |
2020 FY | 287.76 Million HKD | 8.01% |
2020 Q1 | 25.29 Million HKD | -25.35% |
2020 Q4 | 74.97 Million HKD | -40.06% |
2019 Q4 | 33.88 Million HKD | -76.17% |
2019 Q3 | 142.17 Million HKD | 228.33% |
2019 FY | 266.41 Million HKD | 2.95% |
2019 Q2 | 43.3 Million HKD | -7.98% |
2019 Q1 | 47.05 Million HKD | -11.76% |
2018 Q2 | 18.3 Million HKD | -58.79% |
2018 Q4 | 53.32 Million HKD | -62.64% |
2018 FY | 258.78 Million HKD | 44.27% |
2018 Q3 | 142.74 Million HKD | 679.93% |
2018 Q1 | 44.41 Million HKD | 186.84% |
2017 Q3 | 112.33 Million HKD | 258.78% |
2017 Q1 | 20.24 Million HKD | -4.28% |
2017 FY | 179.36 Million HKD | 8.64% |
2017 Q4 | 15.48 Million HKD | -86.22% |
2017 Q2 | 31.31 Million HKD | 54.67% |
2016 Q4 | 21.14 Million HKD | -77.07% |
2016 FY | 165.09 Million HKD | -3.34% |
2016 Q3 | 92.21 Million HKD | 0.0% |
2015 FY | 170.8 Million HKD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 336.01 Million HKD | 35.839% |
Innovative Pharmaceutical Biotech Limited | 6.59 Million HKD | -3169.998% |
China Overseas Nuoxin International Holdings Limited | 180.99 Million HKD | -19.114% |
Prosperous Future Holdings Limited | 470.33 Million HKD | 54.162% |
Huasheng International Holding Limited | 565.9 Million HKD | 61.903% |
Fourace Industries Group Holdings Limited | 268.02 Million HKD | 19.563% |
Evergreen Products Group Limited | 979.24 Million HKD | 77.984% |
EC Healthcare | 4.21 Billion HKD | 94.88% |
Ming Fai International Holdings Limited | 2.06 Billion HKD | 89.571% |
Blue Moon Group Holdings Limited | 7.32 Billion HKD | 97.056% |
SuperRobotics Holdings Limited | 15.08 Million HKD | -1329.554% |
Hyfusin Group Holdings Limited | 866.25 Million HKD | 75.112% |